2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Ception Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis reslizumab - Eosinophilic Esophagitis | Phase 3 | Completed | Ception Therapeutics | 190 | 2008-07-01 | 2017-03-23 |
| Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years Reslizumab, Saline - Eosinophilic Esophagitis | Phase 2 / Phase 3 | Completed | Ception Therapeutics | 227 | 2008-03-01 | 2016-09-02 |
Eosinophilic Esophagitis (2) · Gastroesophageal Reflux (1)
reslizumab (2) · Sodium Chloride (1)
Canada (2) · United States (2)